EUR 23.6
(1.72%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 180.33 Million EUR | 4548.29% |
2022 | 6.8 Million EUR | 69.54% |
2021 | 4.01 Million EUR | 142.45% |
2020 | -9.45 Million EUR | -258.38% |
2019 | 5.96 Million EUR | -86.47% |
2018 | 44.11 Million EUR | 30.47% |
2017 | 33.81 Million EUR | 281.05% |
2016 | 8.87 Million EUR | -66.84% |
2015 | 26.75 Million EUR | 22.81% |
2014 | 21.78 Million EUR | 29.34% |
2013 | 16.84 Million EUR | -30.2% |
2012 | 24.13 Million EUR | 43.35% |
2011 | 16.83 Million EUR | -6.15% |
2010 | 17.93 Million EUR | 73.63% |
2009 | 10.33 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 84.15 Million EUR | 0.0% |
2023 FY | 316.3 Million EUR | 4548.29% |
2023 Q4 | 34.08 Million EUR | 0.0% |
2023 Q2 | 341.3 Thousand EUR | 0.0% |
2022 Q4 | 6.54 Million EUR | 0.0% |
2022 FY | 6.8 Million EUR | 69.54% |
2022 Q2 | 250 Thousand EUR | 0.0% |
2021 Q2 | 426.4 Thousand EUR | 0.0% |
2021 FY | 4.01 Million EUR | 142.45% |
2021 Q4 | 3.58 Million EUR | 0.0% |
2020 Q2 | 126.42 Thousand EUR | 0.0% |
2020 Q4 | -9.58 Million EUR | 0.0% |
2020 FY | -9.45 Million EUR | -258.38% |
2019 Q2 | -229.7 Thousand EUR | 0.0% |
2019 FY | 5.96 Million EUR | -86.47% |
2019 Q4 | 6.19 Million EUR | 0.0% |
2018 Q4 | -12.85 Million EUR | 0.0% |
2018 FY | 44.11 Million EUR | 30.47% |
2018 Q2 | 57.7 Million EUR | 0.0% |
2017 Q2 | 7.38 Million EUR | 0.0% |
2017 FY | 33.81 Million EUR | 281.05% |
2017 Q4 | 26.43 Million EUR | 0.0% |
2016 Q4 | -4.04 Million EUR | 0.0% |
2016 FY | 8.87 Million EUR | -66.84% |
2016 Q2 | -834 Thousand EUR | 0.0% |
2015 Q4 | 16.45 Million EUR | 0.0% |
2015 Q2 | 10.3 Million EUR | 0.0% |
2015 FY | 26.75 Million EUR | 22.81% |
2014 FY | 21.78 Million EUR | 29.34% |
2014 Q2 | 8.9 Million EUR | 0.0% |
2014 Q4 | 12.88 Million EUR | 0.0% |
2013 FY | 16.84 Million EUR | -30.2% |
2013 Q4 | 8.9 Million EUR | 0.0% |
2013 Q2 | 7.94 Million EUR | 0.0% |
2012 Q4 | 3.07 Million EUR | 0.0% |
2012 Q2 | 6.89 Million EUR | 0.0% |
2012 Q1 | 6.89 Million EUR | 0.0% |
2012 FY | 24.13 Million EUR | 43.35% |
2012 Q3 | 3.07 Million EUR | -55.39% |
2011 FY | 16.83 Million EUR | -6.15% |
2010 FY | 17.93 Million EUR | 73.63% |
2009 FY | 10.33 Million EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Apontis Pharma AG | -3.33 Million EUR | 5505.267% |
Dermapharm Holding SE | 342.86 Million EUR | 47.404% |
Evotec SE | 175.05 Million EUR | -3.016% |
MERCK Kommanditgesellschaft auf Aktien | 11.66 Billion EUR | 98.455% |
PharmaSGP Holding SE | 91.63 Million EUR | -96.788% |
SynBiotic SE | 1.5 Million EUR | -11870.834% |